Acanthamoeba Keratitis Market Size Analysis, Growth Opportunities, Pipeline Development Activities, Emerging Therapies, and Epidemiology Forecast | Key Companies – SIFI SpA

DelveInsight has launched a new report on Acanthamoeba Keratitis Market Insights, Epidemiology, and Market Forecast-2032”. 

DelveInsight’s “Acanthamoeba Keratitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Acanthamoeba Keratitis, historical and forecasted epidemiology as well as the Acanthamoeba Keratitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

Some of the key facts of the Acanthamoeba Keratitis Market Report: 

  • Although Acanthamoeba keratitis is uncommon, it can cause eye pain, permanent vision loss, and even blindness 
  • In the 7MM countries, the incidence of Acanthamoeba keratitis is approximately 1 to 33 cases per million contact lens wearers 
  • In the United States, the prevalence of Acanthamoeba keratitis is 1 to 2 new cases per million contact lens wearers 
  • It is evaluated that, approximately 16.7% of the US adults wear contact lenses

Request a sample for the Report:

Key benefits of the report:

  1. Acanthamoeba Keratitis market report covers a descriptive overview and comprehensive insight of the Acanthamoeba Keratitis Epidemiology and Acanthamoeba Keratitis  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Acanthamoeba Keratitis market report provides insights on the current and emerging therapies.
  3. Acanthamoeba Keratitis market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Acanthamoeba Keratitis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Acanthamoeba Keratitis market. 

Got queries? Click here to know more about the Acanthamoeba Keratitis Market Landscape 

Acanthamoeba Keratitis Overview: 

Acanthamoeba keratitis is a rare but deadly eye infection that can cause permanent vision loss or even blindness. Acanthamoeba is a microscopic, free-living ameba (single-celled living organism) that causes this infection. Acanthamoeba keratitis can affect anyone, however, it is particularly frequent in patients who wear soft contact lenses. You’re more likely to have this condition if you: Instead of disinfecting solution, clean your contact lenses with tap water or saline. If you come into contact with water that contains the amoeba, you will get sick. 

Acanthamoeba-caused skin infections that haven’t progressed to the central nervous system can be successfully treated. Because this is a dangerous virus that affects patients with compromised immune systems, early detection is critical for a cure. 

Acanthamoeba Keratitis Symptoms: 

The symptoms of Acanthamoeba Keratitis include –

  • Sensation of something in the eye
  • Pain in eye
  • Eye Redness
  • Blurred vision
  • Excessive tearing
  • Sensitivity to light

Acanthamoeba Keratitis Market  

The dynamics of the Acanthamoeba Keratitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as PHMB 0.02%, and others during the forecasted d 2019-2032. 

Learn more by requesting for sample @Acanthamoeba Keratitis Market Landscape  

Acanthamoeba Keratitis Pipeline Therapies

  • Propamidine
  • PHMB 0.02%

Acanthamoeba Keratitis Pipeline Key Companies

  • SIFI SpA

Table of Contents 

  1. Report Introduction
  2. Executive Summary
  3. SWOT analysis
  4. Acanthamoeba Keratitis Patient Share (%) Overview at a Glance
  5. Acanthamoeba Keratitis Market Overview at a Glance
  6. Acanthamoeba Keratitis Disease Background and Overview
  7. Acanthamoeba Keratitis Epidemiology and Patient Population
  8. Country-Specific Patient Population of Acanthamoeba Keratitis 
  9. Acanthamoeba Keratitis Current Treatment and Medical Practices
  10. Unmet Needs
  11. Acanthamoeba Keratitis Emerging Therapies
  12. Acanthamoeba Keratitis Market Outlook
  13. Country-Wise Acanthamoeba Keratitis Market Analysis (2018–2030)
  14. Market Access and Reimbursement of Therapies
  15. Market drivers
  16. Market barriers
  17. Appendix
  18. Acanthamoeba Keratitis Report Methodology
  19. DelveInsight Capabilities
  20. Disclaimer
  21. About DelveInsight 

Click here to read more about Acanthamoeba Keratitis Market Outlook 2032

Related Reports: 

Diagnostic Imaging Equipment Market

Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.

Invasive Candidiasis Market

“DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Sialidosis Market 

DelveInsight’s “Sialidosis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Filgrastim Biosimilar Insight

DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. 

Pain Management Devices Market

Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 

Latest Reports by DelveInsight

NCFB Market | Metastatic Bone Pain Market | Ventricular Hypertrophy Market | Diagnostic Imaging Equipment Market | Invasive Candidiasis Market | Upper Limb Hypertonia Market | Sialidosis Market | Filgrastim Biosimilar Insight | 3D Cardiac Mapping System Market | Acanthamoeba Keratitis Market | Adult Growth Hormone Deficiency Market | Advanced Cancer Pain Management Market | Apheresis Market | Arteriovenous fistula Market | Automated external defibrillators (AEDs) Market | Balloon Catheters Market | Calciphylaxis Market | Cerebral Aneurysm Market | Chronic Idiopathic Urticaria Market

For more detailed information about the EULAR conference visit:

To know more about our Competitive Services, Click here: Pharma Competitive Intelligence

Also, take a glance at the Blogs by DelveInsight:


About DelveInsight 

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach. 

Media Contact 

Company Name: DelveInsight Business Research LLP

Contact Person: Gaurav Bora

Email: [email protected]

City: Albany

State: New York

Country: United States




Posted on

Leave a Reply

Your email address will not be published.